Study of Genes Related to Breast Cancer and Aneuploidy
Author Information
Author(s): Bièche Ivan, Vacher Sophie, Lallemand François, Tozlu-Kara Sengül, Bennani Hind, Beuzelin Michèle, Driouch Keltouma, Rouleau Etienne, Lerebours Florence, Ripoche Hugues, Cizeron-Clairac Géraldine, Spyratos Frédérique, Lidereau Rosette
Primary Institution: Institut Curie
Hypothesis
The study investigates the role of mitotic spindle checkpoint genes in breast cancer and their potential as diagnostic markers for aneuploidy.
Conclusion
The study identifies several dysregulated genes in breast tumors that may serve as diagnostic or prognostic markers for aneuploidy.
Supporting Evidence
- Forty (52.6%) of the 76 genes were significantly upregulated in the invasive breast tumors compared to normal breast tissues.
- NDC80 was the gene with the strongest upregulation (3.6-fold) in benign breast tumors compared to normal tissues.
- A two-gene expression signature (PLK1 + AURKA) was identified that discriminated between DNA aneuploid and DNA diploid breast tumor samples.
Takeaway
This study looks at how certain genes behave in breast cancer, helping doctors understand which tumors might be more dangerous.
Methodology
Real-time quantitative RT-PCR was used to measure the expression of 76 mitotic spindle checkpoint genes in breast tumor samples.
Limitations
The study's findings need further validation in larger prospective studies.
Participant Demographics
The study involved 47 primary breast tumors from women, including 23 DNA aneuploid and 24 DNA diploid tumors.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website